Go Pro

Enavate Sciences Gp, LLC Top Holdings and 13F Report (2026)

About Enavate Sciences Gp, LLC

Investment Activity

  • Enavate Sciences Gp, LLC has $345.38 million in total holdings as of June 30, 2026.
  • Enavate Sciences Gp, LLC owns shares of 7 different stocks, but just 3 companies or ETFs make up 80% of its holdings.
  • About 0.97% of the portfolio was sold this quarter.
  • This quarter, Enavate Sciences Gp, LLC has purchased 7 new stocks and bought additional shares in 0 stocks.
  • Enavate Sciences Gp, LLC sold shares of 1 stock and completely divested from 0 stocks this quarter.

Largest Holdings

SIONNA THERAPEUTICS INC
$109,008,540
ZENAS BIOPHARMA INC
$99,468,255
Immunome
$76,576,401
BRIDGEBIO ONCOLOGY THERAPEUT
$20,017,329

Largest Sales this Quarter

CAMP4 THERAPEUTICS CORP
765,379 shares (about $3.34M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofEnavate Sciences Gp, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
SIONNA THERAPEUTICS INC
$109,008,5400.0%2,478,03031.6%COM
ZENAS BIOPHARMA INC
$99,468,2550.0%3,919,15928.8%COM
Immunome, Inc. stock logo
IMNM
Immunome
$76,576,4010.0%3,613,79922.2%Healthcare
BRIDGEBIO ONCOLOGY THERAPEUT
$20,017,3290.0%2,626,9465.8%COM NEW
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$17,056,0490.0%7,788,1504.9%Healthcare
UPSTREAM BIO INC
$17,021,1450.0%2,459,7034.9%COM
CAMP4 THERAPEUTICS CORP
$6,229,614$3,344,706 â–¼-34.9%1,425,5411.8%COM

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data